ATE233811T1 - Blutplaettchen-gpiiia p1a1 und -p1a2-epitope, ihre herstellung und verwendung - Google Patents

Blutplaettchen-gpiiia p1a1 und -p1a2-epitope, ihre herstellung und verwendung

Info

Publication number
ATE233811T1
ATE233811T1 AT93900656T AT93900656T ATE233811T1 AT E233811 T1 ATE233811 T1 AT E233811T1 AT 93900656 T AT93900656 T AT 93900656T AT 93900656 T AT93900656 T AT 93900656T AT E233811 T1 ATE233811 T1 AT E233811T1
Authority
AT
Austria
Prior art keywords
gpiiia
disclosed
polypeptides
plateet
epitopes
Prior art date
Application number
AT93900656T
Other languages
English (en)
Inventor
Ronald D Bowditch
Robert Mcmillan
Mark H Ginsberg
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE233811T1 publication Critical patent/ATE233811T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70557—Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/24—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
AT93900656T 1991-12-09 1992-11-24 Blutplaettchen-gpiiia p1a1 und -p1a2-epitope, ihre herstellung und verwendung ATE233811T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/808,457 US5939524A (en) 1991-12-09 1991-12-09 Platelet GPIII P1A1 and P1A2 epitopes, their preparation and use
PCT/US1992/010178 WO1993012127A1 (en) 1991-12-09 1992-11-24 PLATELET GPIIIa P1?A1 AND P1A2¿ EPITOPES, THEIR PREPARATION AND USE

Publications (1)

Publication Number Publication Date
ATE233811T1 true ATE233811T1 (de) 2003-03-15

Family

ID=25198810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93900656T ATE233811T1 (de) 1991-12-09 1992-11-24 Blutplaettchen-gpiiia p1a1 und -p1a2-epitope, ihre herstellung und verwendung

Country Status (11)

Country Link
US (1) US5939524A (de)
EP (1) EP0625157B1 (de)
JP (1) JP4053084B2 (de)
AT (1) ATE233811T1 (de)
AU (1) AU680190B2 (de)
CA (1) CA2125486C (de)
DE (1) DE69232945T2 (de)
DK (1) DK0625157T3 (de)
ES (1) ES2194012T3 (de)
PT (1) PT625157E (de)
WO (1) WO1993012127A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7442370B2 (en) * 2001-02-01 2008-10-28 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
US7276580B2 (en) * 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
JP4571776B2 (ja) * 2002-11-05 2010-10-27 Ｊｘ日鉱日石エネルギー株式会社 潤滑油組成物
WO2004094592A2 (en) 2003-04-18 2004-11-04 Biogen Idec Ma Inc. Polymer-conjugated glycosylated neublastin
GB0315754D0 (en) * 2003-07-04 2003-08-13 Univ Aberdeen Pharmaceutical compositions
DK1786454T3 (da) * 2004-08-19 2010-09-06 Biogen Idec Inc Neublastinvarianter
CA2577690C (en) * 2004-08-19 2013-08-06 Biogen Idec Ma Inc. Refolding transforming growth factor beta family proteins
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
ES2450065T3 (es) * 2006-03-01 2014-03-21 Biogen Idec Ma Inc. Composiciones y métodos para la administración de proteínas de la familia de ligandos del GDNF
GB0701048D0 (en) * 2007-01-18 2007-02-28 Univ Aberdeen A composition
EP2142205B1 (de) 2007-05-01 2014-04-02 Biogen Idec MA Inc. Neublastin Peptide für erhöhte Vaskularisierung im Gewebe mit reduzierter Durchblutung
WO2009020964A2 (en) * 2007-08-08 2009-02-12 Biogen Idec Ma Inc. Anti-neublastin antibodies and uses thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) * 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
NL154598B (nl) * 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US4016043A (en) * 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4356270A (en) * 1977-11-08 1982-10-26 Genentech, Inc. Recombinant DNA cloning vehicle
SE428332B (sv) * 1979-03-08 1983-06-20 Wallac Oy Forfarande for fluorescensspektroskopisk bestemning av biologiskt aktivt emne, sasom hapten, antikropp eller antigen
US4403036A (en) * 1980-12-02 1983-09-06 University Of Iowa Research Foundation Genetic reagents for generating plasmids containing multiple copies of DNA segments
US4416988A (en) * 1980-12-23 1983-11-22 Harvey Rubin Detection and isolation of enkephalin mRNA using a synthetic oligodeoxynucleotide
US4714681A (en) * 1981-07-01 1987-12-22 The Board Of Reagents, The University Of Texas System Cancer Center Quadroma cells and trioma cells and methods for the production of same
US4493795A (en) * 1983-10-17 1985-01-15 Syntex (U.S.A.) Inc. Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture
US4599230A (en) * 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599231A (en) * 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4707404A (en) * 1984-04-03 1987-11-17 Mitsubishi Paper Mills, Ltd. Thermal transfer recording material
US4818678A (en) * 1984-05-04 1989-04-04 Scripps Clinic And Research Foundation Diagnostic system for the detection of cytomegalovirus
US4683136A (en) * 1985-03-06 1987-07-28 Scripps Clinic And Research Foundation Proteinaceous antigens with conformation-independent and conformation-dependent determinants
US4631211A (en) * 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4882145A (en) * 1986-12-09 1989-11-21 Scripps Clinic And Research Foundation T cell epitopes of the hepatitis B virus nucleocapsid protein
US4828527A (en) * 1987-12-04 1989-05-09 Donald Spector Play character
WO1990006953A2 (en) * 1988-12-22 1990-06-28 Genentech, Inc. Method for preparing water soluble polypeptides
US5091302A (en) * 1989-04-27 1992-02-25 The Blood Center Of Southeastern Wisconsin, Inc. Polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic applications thereof
US5177188A (en) * 1990-12-03 1993-01-05 The Scripps Research Institute Methods and compositions for diagnosing chronic immune thrombocytopenic purpura

Also Published As

Publication number Publication date
PT625157E (pt) 2003-07-31
EP0625157A4 (de) 1995-06-28
JPH07502121A (ja) 1995-03-02
US5939524A (en) 1999-08-17
EP0625157B1 (de) 2003-03-05
JP4053084B2 (ja) 2008-02-27
CA2125486C (en) 1999-09-07
EP0625157A1 (de) 1994-11-23
CA2125486A1 (en) 1993-06-24
DE69232945D1 (de) 2003-04-10
AU680190B2 (en) 1997-07-24
WO1993012127A1 (en) 1993-06-24
ES2194012T3 (es) 2003-11-16
AU3224993A (en) 1993-07-19
DE69232945T2 (de) 2003-12-04
DK0625157T3 (da) 2003-06-16

Similar Documents

Publication Publication Date Title
ATE505542T1 (de) Tumorassoziierte antigenderivate der mage-familie,zur herstellung von fusionsproteinen mit t-helper epitope und zusammensetzungen zur impfung
ATE130765T1 (de) Gentechnologisch veränderte immunglobuline.
DE69733247D1 (de) Humanisiertes grünes-fluoreszenzprotein und methoden
EP1190043A4 (de) Glykoprotein vi und dessen anwendungen
ES2009210A6 (es) Un procedimiento para la obtencion de nuevos polipeptidos que proporcionan anticuerpos frente a virus de sida, yno reaccionantes con anticuerpos sida.
ATE268818T1 (de) Ctla4-mutantmoleküle und deren verwendung
DK0757717T3 (da) Papillomavirusvacciner
ATE335078T1 (de) Überexpression von säugetier- und virusproteinen
ATE232237T1 (de) Herstellung von funktionellen, menschlichen urokinaseproteinen
DK37591A (da) Fusionsprotein fra paramyxovirus, fremgangsmaade til fremstilling deraf under anvendelse af rekombinant baculovirus-ekspressionsvektor, vaccine indeholdende proteinet samt dets anvendelse
ATE541930T1 (de) Il-17-homologe polypeptide und ihre therapeutische verwendung
DE69738586D1 (de) Hohe expressionsrate von proteinen
DK0851868T3 (da) Höjniveau-ekspression af proteiner
ATE233811T1 (de) Blutplaettchen-gpiiia p1a1 und -p1a2-epitope, ihre herstellung und verwendung
ATE325882T1 (de) Polypeptide, die mit alfalfamosaikviralen oder ilarviralen kapsiden fusioniert sind
HUP9902438A2 (hu) Parapoxvírus vektorok
DE68917323D1 (de) Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine.
DE59708952D1 (de) Fusionspolypeptid zur beeinflussung von wechselwirkungen zwischen proteinen
ATE196162T1 (de) Toxoplasma gondii-antigene, ihre herstellung und ihre verwendung
DE69841015D1 (de) Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2
DE59101580D1 (de) Trägergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine.
NO922421D0 (no) Collagenbindende protein, samt fremstilling derav
FI971086A7 (fi) Kinaasia sitova proteiini ja sen käyttö
FI870501L (fi) Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut
ATE105335T1 (de) Traegergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0625157

Country of ref document: EP